R E Feder. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Administration, CutaneousAntiemetics/administration & dosageAntiemetics/adverse effectsDelayed-Action PreparationsHumansScopolamine/administration & dosageScopolamine/adverse effectsSubstance Withdrawal Syndrome/etiology
Substances： See more » AntiemeticsDelayed-Action PreparationsScopolamine
Year: 1999 PMID： 10202610 DOI： 10.1097/00002826-199903000-00011
Source DB: PubMed Journal: Clin Neuropharmacol ISSN： 0362-5664 Impact factor: 1.592